DeciBio Analytics launches Dexter, an expert network marketplace for the life science industry

The Dexter network spans various life science cohorts including - but not limited to - single cell genomics, liquid biopsy, pathology, proteomics, and oncology. Examples of past and current projects include:

- Cancer Screening Landscape:

To understand the competitive landscape for early detection and cancer screening in hematology/oncology, users leveraged Dexter to identify and interview 25 stakeholders in the US and EU in four weeks.

- Nanopore Sequencing Analysis:

To characterize adoption, use cases, and pricing of nanopore sequencing instruments in comparison to other NGS technologies, Dexter onboarded 10 US and EU stakeholders in less than three weeks.

- Pharma R&D Assessment:

To characterize pharma R&D allocations and clinical decision support, Dexter users launched an interview campaign for 50 stakeholders in the US, the EU, and Asia.

Dexter offers 2 types of service offerings. The self-service model provides flexibility for customers to lead and conduct their own primary research campaigns. Alternatively, the full-service model includes supplemental services such as interview guides, interview moderation, and summaries.

To learn more about the Dexter expert network or schedule a demo, visit https://dexterexperts.com/ .

About DeciBio

DeciBio Consulting is a strategy consulting firm focused on precision medicine. DeciBio offers advisory services for growth planning, market and opportunity assessment, product and portfolio strategy, and corporate due diligence.

About DeciBio Analytics

DeciBio Consulting’s market intelligence subsidiary, DeciBio Analytics aggregates public and proprietary data to build proprietary data visualization and software products.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200917005826/en/